Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes-Reference-Cited by-同舟云学术

Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes

Published:2012-04-18 Issue:5 Volume:66 Page:465-476
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Harashima S-I.,Ogura M.,Tanaka D.,Fukushima T.,Wang Y.,Koizumi T.,Aono M.,Murata Y.,Seike M.,Inagaki N.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2012.02903.x/fullpdf

Reference26 articles.

1. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

2. Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients;Arai;Endocr J,2010

3. Management of type 2 diabetes: new and future developments in treatment;Tahrani;Lancet,2011

4. Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes;Nonaka;Diabetes Res Clin Pract,2008

5. Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control;Tajima;Diabetol Int,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Correlated to the Renoprotective Effect of Sitagliptin in Patients with Type 2 Diabetes Mellitus: Retrospective Observational Study;Advances in Pharmacological and Pharmaceutical Sciences;2024-01

2. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach;International Journal of Diabetes in Developing Countries;2023-04-19

3. Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes;Iranian Red Crescent Medical Journal;2021-02-18

4. Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin;Journal of Research in Medical Sciences;2021

5. Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway;Minerva Endocrinologica;2020-09